Respondents to King’s Trust survey cited AI and a lack of work experience as reasons they might fail in life More than seven in 10 teens and young adults in the UK say they wish they were not starting their careers in the current economic climate, according to new research from the King’s Trust . The study also found that more than a quarter of people aged 16 to 25 feel they are going to fail in life, highlighting growing anxiety among those entering the labour market. Continue reading... from The Guardian https://ift.tt/pD15uhK via IFTTT
Pembrolizumab is used to treat triple-negative form of disease but researchers say it could be used more widely
Thousands more women with breast cancer could benefit from a blockbuster immunotherapy drug than previously thought, research suggests.
Pembrolizumab, sold under the brand name Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.
Continue reading...from The Guardian https://ift.tt/87bNmid
via IFTTT
Comments
Post a Comment